08 June 2019 : Clinical Research
Pharmacological Targets and the Biological Mechanisms of Formononetin for Alzheimer’s Disease: A Network Analysis
Hai Xiao1BDF, Xinyue Qin1BDF, Jinping Wan1CF, Rong Li2ACDFG*DOI: 10.12659/MSM.916662
Med Sci Monit 2019; 25:4273-4277
Abstract
BACKGROUND: This study aimed to identify the pharmacological targets and mechanisms of action of the traditional Chinese medicine, formononetin, in the treatment of Alzheimer’s disease (AD) using network pharmacological analysis.
MATERIAL AND METHODS: Targets of AD were obtained by using DisGeNET gene discovery platform, the herbal ingredients target (HIT) database, the SuperPred, and the SwissTargetPrediction compound target prediction platforms. Pathogenic and therapeutic targets were imported to the STRING biological database, and Cytoscape network integration software was used to construct component-target and disease-target interaction networks. Core targets were identified by topological analysis and were further tested to identify the biological processes and signaling pathways.
RESULTS: Seven key target genes for formononetin in the treatment of patients with AD were identified, including estrogen receptor alpha (ESR1), peroxisome proliferator-activated receptor gamma (PPARG), tumor protein p53 (TP53), sirtuin 1 (SIRT1), tumor necrosis factor (TNF), cytochrome P450 19A1 (CYP19A1), and nuclear factor (erythroid-derived 2)-like 2 (NFE2L2). The biological processes included hormone metabolism, regulation of nucleoside, nucleotide and nucleic acid metabolism, apoptosis, energy pathways, metabolism, cell communication, and signal transduction. The signaling pathways included histone acetylation and deacetylation (HDAC) class I, regulation of p38-alpha/beta, p38 mitogen-activated protein kinase (MAPK) signaling pathway, bone morphogenetic protein (BMP) receptor signaling, interleukin-1 (IL1) mediated signaling events, the tumor necrosis factor (TNF) receptor signaling pathway, and cytoplasmic and nuclear Smad2/3 signaling.
CONCLUSIONS: Pharmacological network analysis was used to identify the gene targets and mechanisms of formononetin treatment in patients with AD.
Keywords: Alzheimer Disease, Behavior and Behavior Mechanisms, Neuropharmacology, Computational Biology, Drugs, Chinese Herbal, Gene Expression Regulation, Gene Regulatory Networks
Editorial
01 March 2025 : Editorial
Editorial: The World Health Organization (WHO) Updated List of Emerging and Potentially Pandemic Pathogens Includes Yersinia pestis as Plague Vaccines Await Clinical TrialsDOI: 10.12659/MSM.948672
Med Sci Monit 2025; 31:e948672
In Press
Review article
Regulatory Efforts and Health Implications of Energy Drink Consumption by Minors in PolandMed Sci Monit In Press; DOI: 10.12659/MSM.947124
Review article
Current Trends and Innovations in Oral and Maxillofacial ReconstructionMed Sci Monit In Press; DOI: 10.12659/MSM.947152
Clinical Research
The Role of the Vojta Method in Diagnosing and Enhancing Motor Skills in Preterm Infants: A Prospective Ope...Med Sci Monit In Press; DOI: 10.12659/MSM.945495
Clinical Research
Comparative Outcomes of Robot-Assisted vs Traditional Laparoscopic Ureteral Reimplantation for Lower Ureter...Med Sci Monit In Press; DOI: 10.12659/MSM.946803
Most Viewed Current Articles
17 Jan 2024 : Review article 7,354,048
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
16 May 2023 : Clinical Research 702,440
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Mar 2024 : Editorial 27,976
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and ...DOI :10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
28 Jan 2024 : Review article 22,314
A Review of IgA Vasculitis (Henoch-Schönlein Purpura) Past, Present, and FutureDOI :10.12659/MSM.943912
Med Sci Monit 2024; 30:e943912